Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decatecholaminisation With Dexmedetomidine in Septic Shock
NCT05283083Phase 2Completed
- Sponsor
- Mansoura University
- Start
- Mar 2022
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexmedetomidine in septic shock, sponsored by Mansoura University. Started Mar 2022; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT05283083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05283083.